These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3518970)

  • 1. Studies on chemical carcinogens and mutagens. XXXV. Standardization of mutagenic capacities of several common alkylating agents based on the concentration-time integrated dose.
    Hakura A; Mizuno Y; Goto M; Kawazoe Y
    Chem Pharm Bull (Tokyo); 1986 Feb; 34(2):775-80. PubMed ID: 3518970
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on chemical carcinogens and mutagens. XXXVI. Apparent activation energy from mutagenic modification induced in E. coli by alkylating agents. Estimation from mutation frequency.
    Hakura A; Kawazoe Y
    Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1728-34. PubMed ID: 3521919
    [No Abstract]   [Full Text] [Related]  

  • 3. Discrimination of mutagenic intermediates derived from alkylating agents by mutational patterns generated in Escherichia coli.
    Elespuru RK; Stupar LL; Gordon JA
    Carcinogenesis; 1991 Jul; 12(7):1161-7. PubMed ID: 2070480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on chemical carcinogens and mutagens. XXXIII. Mutation frequencies induced by combinations of methylating and/or ethylating mutagens.
    Kawazoe Y; Hakura A; Kohda K
    Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):250-5. PubMed ID: 3516420
    [No Abstract]   [Full Text] [Related]  

  • 5. [MUTAGENIC AND CANCERIGENIC ACTIONS OF ALKYLATING AGENTS].
    VERLY WG
    Rev Fr Etud Clin Biol; 1964 Oct; 9():878-83. PubMed ID: 14226831
    [No Abstract]   [Full Text] [Related]  

  • 6. Genotoxic potency of monofunctional alkylating agents in E. coli: comparison with carcinogenic potency in rodents.
    Quinto I; Tenenbaum L; Radman M
    Mutat Res; 1990 Feb; 228(2):177-85. PubMed ID: 2405262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential carcinogenic and mutagenic industrial chemicals. I. Alkylating agents.
    Fishbein L
    J Toxicol Environ Health; 1980; 6(5-6):1133-77. PubMed ID: 7007656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of methylhydrazines to mutagenic methylating derivatives and inducers of the adaptive response of Escherichia coli to alkylation damage.
    Sedgwick B
    Cancer Res; 1992 Jul; 52(13):3693-7. PubMed ID: 1617641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenic potency in rodents versus genotoxic potency in E. coli: a correlation analysis for bifunctional alkylating agents.
    Quinto I; Radman M
    Mutat Res; 1987 Dec; 181(2):235-42. PubMed ID: 3317026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analyses of radiation- and chemical-induced lethality and mutagenesis in Chinese hamster ovary cells.
    Hsie AW; O'Neill JP; Couch DB; SanSebastian JR; Brimer PA; Machanoff R; Fuscoe JC; Riddle JC; Li AP; Forbes NL; Hsie MH
    Radiat Res; 1978 Dec; 76(3):471-92. PubMed ID: 216050
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection of Chinese hamster cells against the cytotoxic and mutagenic effects of alkylating agents by transfection of the Escherichia coli alkyltransferase gene and a truncated derivative.
    Fox M; Brennand J; Margison GP
    Mutagenesis; 1987 Nov; 2(6):491-6. PubMed ID: 3328039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modification of the mutagenic effect of ethylmethane sulfonate by adrenaline].
    Semenov VV; Ibragimova MIa; Barabanshchikov BI
    Biull Eksp Biol Med; 1998 Oct; 126(10):427-9. PubMed ID: 9825142
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimating maximum limits to mutagenic potency from cytotoxic potency.
    Carver JH; Hatch FT; Branscomb EW
    Nature; 1979 May; 279(5709):154-6. PubMed ID: 440419
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of some chemical mutagens and carcinogens on nucleic acids.
    Lawley PD
    Prog Nucleic Acid Res Mol Biol; 1966; 5():89-131. PubMed ID: 5337700
    [No Abstract]   [Full Text] [Related]  

  • 15. An E. coli ada transgenic clone of Nicotiana tabacum var. Xanthi has increased sensitivity to the mutagenic action of alkylating agents, maleic hydrazide and gamma-rays.
    Velemínský J; Angelis K; Babůrek I; Gichner T; Satava J; Bríza J; Margison GP
    Mutat Res; 1994 May; 307(1):193-200. PubMed ID: 7513797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
    Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B
    IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the DNA primary structure effect on induction of mutations by alkylating agents].
    Rogozin IB; Berikov VB; Vasiunina EA; Sinitsina OI
    Genetika; 2001 Jun; 37(6):854-61. PubMed ID: 11517774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenic and promutagenic properties of DNA adducts formed by vinyl chloride metabolites.
    Barbin A; Bartsch H
    IARC Sci Publ; 1986; (70):345-58. PubMed ID: 3539790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Wheeler GP; Adamson DJ; Webster J
    Cancer Res; 1985 Jul; 45(7):3400-2. PubMed ID: 4005864
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncogenesis, mutagenesis, DNA damage, and cytotoxicity in cultured mammalian cells treated with alkylating agents.
    Peterson AR; Peterson H; Heidelberger C
    Cancer Res; 1979 Jan; 39(1):131-8. PubMed ID: 761183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.